| CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors VE Anderson, MI Walton, PD Eve, KJ Boxall, L Antoni, JJ Caldwell, ... Cancer research 71 (2), 463-472, 2011 | 118 | 2011 |
| Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2 S Hilton, S Naud, JJ Caldwell, K Boxall, S Burns, VE Anderson, L Antoni, ... Bioorganic & medicinal chemistry 18 (2), 707-718, 2010 | 74 | 2010 |
| Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy JP Sanderson, DJ Crowley, GE Wiedermann, LL Quinn, KL Crossland, ... OncoImmunology 9 (1), 1682381, 2020 | 65 | 2020 |
| Structure-based design of potent and selective 2-(quinazolin-2-yl) phenol inhibitors of checkpoint kinase 2 JJ Caldwell, EJ Welsh, C Matijssen, VE Anderson, L Antoni, K Boxall, ... Journal of medicinal chemistry 54 (2), 580-590, 2011 | 58 | 2011 |
| Tuning T‐Cell Receptor Affinity to Optimize Clinical Risk‐Benefit When Targeting Alpha‐Fetoprotein–Positive Liver Cancer RY Docta, T Ferronha, JP Sanderson, T Weissensteiner, GR Pope, ... Hepatology 69 (5), 2061-2075, 2019 | 54 | 2019 |
| Novel sfi1 Alleles Uncover Additional Functions for Sfi1p in Bipolar Spindle Assembly and Function VE Anderson, J Prudden, S Prochnik, TH Giddings Jr, KG Hardwick Molecular biology of the cell 18 (6), 2047-2056, 2007 | 42 | 2007 |
| Enhanced activity of second-generation MAGE-A4 SPEAR T-cells through co-expression of a CD8α homodimer VE Anderson, AM Weber, GE Wiedermann, A Pachnio, S Dauleh, ... Proceedings: AACR Annu Meeting 79 (2313), 10.1158, 2019 | 6 | 2019 |
| Corrigendum to “Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2”[Bioorg. Med. Chem. 18 (2010) 707] S Hilton, S Naud, JJ Caldwell, K Boxall, S Burns, VE Anderson, L Antoni, ... Bioorganic & Medicinal Chemistry 18 (12), 4591, 2010 | 4 | 2010 |
| Enhancing Efficacy of TCR-engineered CD4+ T Cells Via Coexpression of CD8α VE Anderson, SS Brilha, AM Weber, A Pachnio, GE Wiedermann, ... Journal of Immunotherapy 46 (4), 132-144, 2023 | 2 | 2023 |
| Next-Generation, Inducible IL-7-Expressing, Tumor-Infiltrating Lymphocytes by Lentiviral Vector Genetic Modification for Clinical Application MD Crowther, MCW Westergaard, P Debnam, V Anderson, GR Pope, ... MOLECULAR THERAPY 30 (4), 160-160, 2022 | 2 | 2022 |
| Selection, engineering, and in vivo testing of a human leukocyte antigen–independent T-cell receptor recognizing human mesothelin MJ Hiscox, A Wasmuth, CL Williams, JN Foot, GE Wiedermann, V Fadda, ... PloS one 19 (4), e0301175, 2024 | | 2024 |
| CCT241533 is a novel, potent and selective inhibitor of CHK2 and potentiates the cellular effects of PARP inhibitors VE Anderson, PD Eve, MI Walton, JJ Caldwell, LH Pearl, AW Oliver, ... Cancer Research 70 (8_Supplement), 3503-3503, 2010 | | 2010 |
| Sfi1p has multiple roles in the spindle pole body cycle VE Anderson KB thesis scanning project 2015, 2006 | | 2006 |
